Comparison of cell proliferation in the centre and advancing fronts of oral squamous cell carcinomas using Ki-67 index

Cell Proliferation

Volumn 36, Issue 5, 2003, Pages 255-264

  Dissanayake, U ^a,b   Johnson, N W ^b   Warnakulasuriya, K A A S ^b,c  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CELL INVASION; CELL PROLIFERATION; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PROGNOSIS; SQUAMOUS CELL CARCINOMA; CELL DIVISION; MITOSIS INDEX; MOUTH TUMOR; PATHOLOGY;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MITOTIC INDEX; MOUTH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0142024824     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.2003.00282.x     Document Type: Article

References (37)

1. ALLISON RT, BEST T (1998) p53, PCNA and Ki67 expression in oral squamous cell carcinoma: the vagaries of fixation and microwave enhancement of immunocytochemistry. J. Oral Pathol. Med. 27, 434.
2. BAISCH H, GERDES J (1987) Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation associated antibody Ki67 and propidium iodide: analysis of flow cytometry. Cell Tissue Kinetics 20, 387.
3. BEGG AC, HAUSTERMANS K, HART AA, DISCHE S, SAUNDERS M, ZACKRISSON B, GUSTAFFSON H, COUCKE P, PASCHOUD N, HOYER M, OVERGAARD J, ANTOGNONI P, RICHETTI A, BOURHIS J, BARTELINK H, HORIOT JC, CORVO R, GIARETTI W, AWWAD H, SHOUMAN T, JOUFFROY T, MACIOROWSKI Z, DOBROWSKY W, STRUIKMANS H, WILSON G et al. (1999) The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicentre analysis. Radiother. Oncol. 50, 13.
4. BROWN DC, GATTER KC (1990) Invited review-monoclonal Ki67: its use in histopathology. Histopathology 17, 489.
5. BRYNE M (1991) Prognostic value of various molecular and cellular features in oral squamous cell carcinomas: a review. J. Oral Pathol. Med. 20, 413.
6. BRYNE M, KOPPANG HS, LILLENG R, STENE T, BANG G, DABELSTEEN E (1989) New malignancy grading is a better prognostic indicator than Borders' grading in oral squamous cell carcinomas. J. Oral Pathol. Med. 18, 432.
7. BRYNE M, NIELSEN K, KOPPANG HS, DABELSTEEN E (1991) Reproducibility of two malignancy grading systems with reportedly prognostic value for oral cancer patients. J. Oral Pathol. Med. 20, 369.
8. BRYNE M, KOPPANG HS, LILLENG R, KJAERHEIM A (1992) Malignancy grading of deep invasive margins of oral squamous cell carcinomas has high prognostic value. J. Pathol. 166, 375.
9. BRYNE M, JENSSEN N, BOYSEN M (1995) Histological grading in the deep infiltrative front of T1 andT2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch. 427, 277.
10. CHAUVAL P, COURDI A, GIOANNI J, VALLICIONI J, SANTINI J, DEMARD F (1989) The labelling index: a prognostic factor in head and neck carcinoma. Radiother. Oncol. 14, 231.
11. COUTURE C, RAYBAUD-DIOGENE H, TETU B, BAIRATI I, MURRAY D, ALLARD J, FORTIN A (2002) p53 and Ki67 as markers of radioresistance in head and neck carcinoma. Cancer 94, 713.
12. GERDES J, LEMKE H, WACHER H, HSCHWAB U, STEIN H (1984) Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki67. J. Immunol. 133, 1710.
13. GIROD SC, KRUEGER G, PAPE HD (1993) p53 and Ki67 expression in preneoplastic and neoplastic lesions of the oral mucosa. Int. J. Oral Maxillofac. Surg. 22, 285.
14. GIROD SC, PFEIFFER P, RIES J, PAPE HD (1998) Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous carcinoma. Br. J. Oral Maxillofac. Surg. 36, 252.
15. HALL PA, RICHARDS MA, GREGORY WM, D'ARDENNE AJ, LISTER TA, STANSFELD AG (1988) The prognostic value of Ki67 immunostaining in non-Hodgkins lymphoma. J. Pathol. 154, 223.
16. JONES AS, ROLAND NJ, CASLIN W, COOKE TG, COOKE LD, FORSTER G (1994) A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck. J. Laryngol. Otol. 108, 859.
17. KEARSLEY JH, FURLONG KL, COOK RA, WATERS MJ (1990) An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. Br. J. Cancer 61, 821.
18. KREIPE H, ALM P, OLSSON H, HAUBERG M, FISCHER L, PARWARESCH R (1993) Prognostic significance of a formalin resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1. Am. J. Pathol. 142, 651.
19. KUWANO H, SAEKI H, KAWAGUCHI H, SONODA K, NAKASHIMA H, TOH Y, SUGIMACHI K (1998) Proliferative activity of cancer cells in front and center areas of carcinoma in situ and invasive sites of esophageal squamous cell carcinoma. Int. J. Cancer. 78, 149.
20. LIU M, LAWSON G, DELOS M, JAMRAT J, IDE C, COCHE E, WEYNARD B, DESUTER G, HAMOIR M, REMACLE M, MARBAIX E (2003) Predictive value of the fraction of cancer cells immunolabelled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations. Head & Neck. 25, 280.
21. NG IOL, LAM KY, NG M, REGEZI JA (1999) Expression of p21/waf1 in oral squamous cell carcinomas-correlation with p53 and mdm2 and cellular proliferation index. Eur. J. Cancer B. Oral Oncol. 35, 63.
22. PIFFKO J, BANKFALVI A, OFNER D, KUSCH F, BOCKER W, JOOS U, SCHMID KW (1996) In situ assessment of cell proliferation at the invasive front of oral squamous cell carcinoma. Virchows Arch. 429, 229.
23. ROLAND NJ, CASLIN AW, BOWIE GL, JONES AS (1994) Has the cellular proliferation marker Ki67 any clinical relevance in squamous cell carcinoma of the head and neck? Clin. Otolaryngol. 19, 13.
24. ROLAND J, HANS J, WELKOBORSKY MANN WJ, HOFKEN F, DIENES HP, FREUE JE (1996) Heterogeneity of squamous cell carcinomas of the head and neck-analysis of tumour biopsy factors and proliferation rates. Laryngoscope 106, 1170.
25. SARBIA M, BITTINGER F, PORSCHEN R, DUTKOWSKI P, TORZEWSKI M, WILLERS R, GABBERT HE (1996) The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus. Br. J. Cancer. 74, 1012.
26. SCOTT RJ, HALL PA, HALDANE JS, VAN NOORDEN S, PRICE Y, LANE DP, WRIGHT NA (1991) Comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J. Pathol. 165, 173.
27. SHEPHERD NA, RICHMAN PI, INGLAND J (1988) Ki67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlation. J. Pathol. 155, 213.
28. SILVESTRINI F, BUSSANI R, PAVLETIC N, MANNONE T, BOSATRA A (1997) From epithelial dysplasia to squamous cell carcinoma of the head and neck region: evaluative and prognostic histopathological markers. Acta Otolaryngol. Suppl. 527, 49.
29. SLEDGE GW, EBLE JN, ROTH BJ, WUHRMAN BP, FINEBERG N, EINHORN LH (1988) Relation of proliferative activity to survival in patients with advance germ cell cancer. Cancer Res. 48, 3864.
30. SLOOTWEG PJ, KOOLE R, HORDIJK GJ (1994) The presence of p53 protein in relation to Ki67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Eur. J. Cancer B Oral Oncol. 30b, 138.
31. THOMPSON PJ, SOAMES JV, BOOTH C, O'SHEA JA (2002) Epithelial cell proliferative activity and oral cancer progression. Cell Prolif. 35, 110.
32. TUBINA M, COURDI A (1989) Cell proliferation kinetics in human solid tumours: relation to probability of metastatic dissemination and long term survival. Radiother. Oncol. 15, 1.
33. TUMULURI V, THOMAS GA, FRASER IS (2002) Analysis of Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinoma. J. Oral Pathol. Med. 31, 598.
34. WARNAKULASURIYA KAAS (1976) Cell Proliferation of Human Oral Mucosa. PhD Thesis, University of Glasgow.
35. WARNAKULASURIYA KAAS JOHNSON NW (1994) Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinomas. J. Oral Pathol. Med. 23, 246.
36. WARNAKULASURIYA KAAS, JOHNSON NW (1996) Importance of proliferation markers in oral pathology. In: Scifert G, ed. Current Topics in Pathology. p. 147. Berlin: Springer.
37. ZOELLER J, FLENTJE M, SINN P, BORN IA (1993) Evaluation of AgNOR and Ki67 antigen as cell kinetics parameters in oral dysplasias and carcinomas. Anat. Cell. Pathol. 7, 77.